Vanguard Group’s LifeMD LFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$6.89M Sell
2,021,704
-205,167
-9% -$996K ﹤0.01% 3135
2025
Q3
$15.1M Buy
2,226,871
+140,749
+7% +$1.16M ﹤0.01% 2763
2025
Q2
$28.4M Buy
2,086,122
+205,617
+11% +$1.94M ﹤0.01% 2390
2025
Q1
$10.2M Buy
1,880,505
+120,279
+7% +$682K ﹤0.01% 2833
2024
Q4
$8.71M Buy
1,760,226
+57,660
+3% +$302K ﹤0.01% 3029
2024
Q3
$8.92M Buy
1,702,566
+184,022
+12% +$1.06M ﹤0.01% 3015
2024
Q2
$10.4M Buy
1,518,544
+363,351
+31% +$3.32M ﹤0.01% 2891
2024
Q1
$11.9M Buy
1,155,193
+128,701
+13% +$951K ﹤0.01% 2859
2023
Q4
$8.51M Buy
1,026,492
+76,028
+8% +$547K ﹤0.01% 3041
2023
Q3
$5.94M Buy
950,464
+219,351
+30% +$951K ﹤0.01% 3173
2023
Q2
$3.18M Buy
731,113
+22,978
+3% +$51K ﹤0.01% 3499
2023
Q1
$1.2M Hold
708,135
﹤0.01% 3860
2022
Q4
$1.37M Buy
708,135
+466
+0.1% +$1.04K ﹤0.01% 3798
2022
Q3
$1.39M Sell
707,669
-102,269
-13% -$244K ﹤0.01% 3884
2022
Q2
$1.65M Hold
809,938
﹤0.01% 3890
2022
Q1
$2.86M Sell
809,938
-90,642
-10% -$322K ﹤0.01% 3794
2021
Q4
$3.48M Buy
900,580
+153,289
+21% +$724K ﹤0.01% 3802
2021
Q3
$4.64M Buy
747,291
+15,277
+2% +$130K ﹤0.01% 3709
2021
Q2
$8.62M Buy
732,014
+24,920
+4% +$287K ﹤0.01% 3285
2021
Q1
$11.2M Buy
+707,094
New +$12.7M ﹤0.01% 3087

Other funds holding LFMD

Vanguard Group's LFMD Position: Q4 2025 in Review

Vanguard Group reduced its LifeMD (LFMD) stake by 9.2% in Q4 2025, selling an estimated $996K and leaving 2,021,704 shares worth $6.89M. The position accounts for ﹤0.01% of the portfolio, ranked #3135.

Vanguard Group first reported a position in LFMD in Q1 2021 and has held it in 20 quarters since. The position peaked at $28.4M in Q2 2025. 104 funds tracked by Wall St. Rank hold LFMD as of Q4 2025.

  • Vanguard Group held 2,021,704 shares of LifeMD worth $6.89M as of Q4 2025.
  • Vanguard Group sold 205,167 LifeMD shares in Q4 2025, an estimated $996K.
  • LifeMD made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3135 holding.
  • Vanguard Group first reported a position in LifeMD in Q1 2021 and has held it in 20 quarters since.
  • Vanguard Group's LifeMD position peaked at $28.4M in Q2 2025.
  • 104 funds tracked by Wall St. Rank held LifeMD as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.